Literature DB >> 1737800

Regulated expression of alpha 2,6-sialyltransferase by the liver-enriched transcription factors HNF-1, DBP, and LAP.

E C Svensson1, P B Conley, J C Paulson.   

Abstract

Tissue-specific carbohydrate structures are thought to result from the selective expression of specific terminal glycosyltransferases responsible for their synthesis. However, little is known about the regulation of the expression of these enzymes. Previous analysis of the distribution of one such enzyme, beta-galactoside alpha 2,6-sialyltransferase, revealed that its expression is tissue restricted, with highest levels being found in the liver. Examination of the gene suggested that its expression is regulated at the level of transcription by multiple promoters, one of which is strongly active in the liver. In this present work, an analysis of the liver-restricted promoter was undertaken to identify the promoter elements necessary for liver-restricted expression. Footprinting studies, 5' deletion analysis, and site-directed mutagenesis identified two cis-elements which were potentially important in the tissue-specific expression of this promoter. One of these elements contains a consensus binding site for the liver-enriched transcription factor hepatocyte nuclear factor-1 alpha, while the other is a consensus binding site for the liver-specific factors D-binding protein and liver-enriched transcriptional activator protein. Expression vectors containing cDNAs of these factors are capable of trans-activating transcription of the alpha 2,6ST promoter, demonstrating their ability to regulate transcription of this promoter. Together, these results suggest that tissue-specific glycosylation can be regulated at the level of transcription by the same factors involved in the expression of a number of other tissue-specific genes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1737800

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene.

Authors:  C Koike; R P Friday; I Nakashima; P Luppi; J J Fung; A S Rao; T E Starzl; M Trucco
Journal:  Transplantation       Date:  2000-11-15       Impact factor: 4.939

2.  Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells.

Authors:  M A Recchi; A Harduin-Lepers; Y Boilly-Marer; A Verbert; P Delannoy
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

3.  Preferential reduction of the alpha-2-6-sialylation from cell surface N-glycans of human diploid fibroblastic cells by in vitro aging.

Authors:  Tomomi Tadokoro; Kiyotaka Yamamoto; Iku Kuwahara; Hirosuke Fujisawa; Masahiko Ikekita; Akiyoshi Taniguchi; Takeshi Sato; Kiyoshi Furukawa
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

4.  Murine hepatic beta-galactoside alpha 2,6-sialyltransferase gene expression involves usage of a novel upstream exon region.

Authors:  Y P Hu; M Dalziel; J T Lau
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

5.  Sialyltransferase activity in FR3T3 cells transformed with ras oncogene: decreased CMP-Neu5Ac:Gal beta 1-3GalNAc alpha-2,3-sialyltransferase.

Authors:  P Delannoy; H Pelczar; V Vandamme; A Verbert
Journal:  Glycoconj J       Date:  1993-02       Impact factor: 2.916

6.  Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene.

Authors:  L K McGlynn; C R Mueller; M Begbie; C R Notley; D Lillicrap
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

7.  The expression of CMP-NeuAc: Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase [EC 2.4.99.1] and glycoproteins bearing alpha 2,6-linked sialic acids in human brain tumours.

Authors:  H Yamamoto; Y Kaneko; D Vandermulen; D Kersey; E Mkrdichian; L Cerullo; J Leestma; J R Moskal
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

8.  Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma.

Authors:  Terence C W Poon; Clarissa H S Chiu; Paul B S Lai; Tony S K Mok; Benny Zee; Anthony T C Chan; Joseph J Y Sung; Philip J Johnson
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

Review 9.  The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role.

Authors:  F Dall'Olio
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

10.  Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter.

Authors:  C Gregori; A Kahn; A L Pichard
Journal:  Nucleic Acids Res       Date:  1993-02-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.